Description
Afatinib prolongs survival of non-small cell lung cancer patients with an exon 19 deletion and delays progression in patients with squamous cell carcinoma of the lung
€2.42
Afatinib prolongs survival of non-small cell lung cancer patients with an exon 19 deletion and delays progression in patients with squamous cell carcinoma of the lung
Reviews
There are no reviews yet.